Skip to main content
. 2022 Feb 9;107(6):e2502–e2512. doi: 10.1210/clinem/dgac071

Table 1.

Population characteristics

Eligible population(n = 18 913) Case-cohort population (n = 312)
Non-CKD (n = 159) CKD (n = 153)
Cohort (n = 111) Cases (n = 48) Cohort (n = 112) Cases (n = 48)
Demography
Age, years 53 (48-61)a 53 (46-60) 57 (51-63)b 64 (59-67) 60 (55-66)b
Sex, female 9587 (50.7) 51 (45.9) 35 (69.2)b 48 (42.9) 31 (64.6)b
White ethnicity 16937 (89.6) 103 (92.8) 44 (91.7) 104 (92.9) 45 (93.8)
Clinical parameters
eGFR (mL/min/1.73 m2) 90 (78-99)a 90 (79-100) 91 (81-99) 56 (50-59) 52 (46-56)b
Body mass index (kg/m2) 27 ± 5 28 ± 5 28 ± 6 30 ± 6 29 ± 6
Active smoking 3593 (19.0) 20 (18.0) 4 (8.3) 14 (12.5) 16 (33.3)b
Weekly alcohol servings 2 (0-6)a 3 (1-7) 1 (0-5)b 1 (0-3) 1 (0-5)
Prior fracture 655 (3.5) 3 (2.7) 4 (8.3) 2 (1.8) 5 (10.4)b
Secondary osteoporosis 2888 (15.3) 18 (16.2) 13 (27.1)b 27 (24.1) 15 (31.3)
Diabetes 1876 (9.9)a 10 (9.0) 4 (8.3) 25 (22.3) 8 (16.7)
Cardiovascular disease 1304 (6.9)a 8 (7.2) 2 (4.2) 21 (18.8) 9 (18.8)
Calcaneal QUS stiffness index 103 ± 19 104 ± 17 94 ± 20b 102 ± 19 94 ± 20b
Medication
Glucocorticoids 136 (0.7)a 0 (0) 0 (0) 3 (2.7) 3 (6.3)
Bisphosphonates 683 (3.6) 2 (1.8) 7 (14.6)b 9 (8.0) 7 (14.6)
Hormonal replacement therapy 1351 (3.6) 8 (7.2) 8 (16.7) 7 (6.3) 3 (6.3)
Oral contraceptives 268 (1.4) 0 (0) 1 (2.1) 0 (0) 0 (0)
Mineral parameters
cFGF23, RU/mL 80 (73-91) 79 (73-98) 88 (79-105) 92 (79-114)
α-Klotho, pg/mL 677 (565-877) 713 (583-862) 662 (543-831) 651 (498-783)
PTH, ng/L 17.3 (11.6-23.1) 14.9 (8.9-23.7) 19.7 (11.3-27.5) 20.8 (13.0-28.3)
Phosphate, mmol/L 1.10 ± 0.21 1.07 ± 0.20 1.08 ± 0.22 1.15 ± 0.28
Calcium, mmol/L 2.38 ± 0.10 2.38 ± 0.09 2.36 ± 0.11 2.37 ± 0.13

Continuous variables are presented as means (SD) or medians (interquartile range) according to their distribution. Categorical variables are presented as counts (percentages). Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; PTH, parathyroid hormone. QUS, quantitative ultrasound.

aIndicates a P value < 0.05 for non-CKD vs CKD comparison.

bIndicates a P value < 0.05 for cases vs cohort patients in a given CKD status.